Your browser doesn't support javascript.
loading
Nano toolbox in immune modulation and nanovaccines.
Azharuddin, Mohammad; Zhu, Geyunjian Harry; Sengupta, Anirban; Hinkula, Jorma; Slater, Nigel K H; Patra, Hirak K.
Afiliação
  • Azharuddin M; Department of Biomedical and Clinical Sciences (BKV), Linköping University, Linköping, Sweden.
  • Zhu GH; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
  • Sengupta A; Department of Biomedical and Clinical Sciences (BKV), Linköping University, Linköping, Sweden.
  • Hinkula J; Department of Biomedical and Clinical Sciences (BKV), Linköping University, Linköping, Sweden.
  • Slater NKH; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
  • Patra HK; Department of Surgical Biotechnology, University College London, London, UK. Electronic address: hirak.patra@ucl.ac.uk.
Trends Biotechnol ; 40(10): 1195-1212, 2022 10.
Article em En | MEDLINE | ID: mdl-35450779
Despite the great success of vaccines over two centuries, the conventional strategy is based on attenuated/altered microorganisms. However, this is not effective for all microbes and often fails to elicit a protective immune response, and sometimes poses unexpected safety risks. The expanding nano toolbox may overcome some of the roadblocks in vaccine development given the plethora of unique nanoparticle (NP)-based platforms that can successfully induce specific immune responses leading to exciting and novel solutions. Nanovaccines necessitate a thorough understanding of the immunostimulatory effect of these nanotools. We present a comprehensive description of strategies in which nanotools have been used to elicit an immune response and provide a perspective on how nanotechnology can lead to future personalized nanovaccines.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Nanopartículas Idioma: En Revista: Trends Biotechnol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Nanopartículas Idioma: En Revista: Trends Biotechnol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia